Arnela Saljic

PhD student, cand.pharm

Research Profile:

I take a deep interest in cardiac physiology and arrhythmias and in particular the molecular pathophysiology of atrial fibrillation. I am currently participating in a project looking at the cardiac effects of high intensity training in horses and atrial fibrillation where I am focusing on the anatomical and electrophysiological substrates for atrial fibrillation on a molecular level.

I graduated as a cand.pharm from the School of Pharmaceutical Sciences at the University of Copenhagen in 2016 and started my PhD Fellowship in Molecular Mechanisms of Atrial Fibrillation at the Laboratory of Cardiac Physiology (University of Copenhagen) in 2017 where I also conducted my research for my master thesis. A part of my PhD I have spent in Professor Prash Sanders Laboratory at the Center for Heart Rhythm Disorders in Adelaide (South Australia) participating in a research project concerning inflammation in the atrium of obese sheep. 



  • Kim Boddum, Arnela Saljic, Thomas Jespersen and Alex Hørby Christensen (2018): ‘Atrial fibrillation, ventricular arrhythmias and reversible cardiomyopathy caused by a novel SCN5A variant’, Cardiology. 140(1):8-13. 
  • Anders Sonne Munch, Arnela Saljic, Kim Boddum, Morten Grunnet, Charlotte Haugaard and Thomas Jespersen (2018): ‘Pharmacological rescue of mutated KV3.1 ion-channel linked to progressive myoclonus epilepsies’, Euro J Pharmacol. 15;833:255-262. 
  • Martin Nybo Andersen, Lasse Skibsbye, Arnela Saljic, Hanne Borger Rasmussen and Thomas Jespersen (2018): ‘Regulation of KV1.4 potassium channels by PKC and AMPK kinasess’. Channels. 12(1):34-44.